Tumor Growth Rate Is an Early Indicator of Antitumor Drug Activity in Phase I Clinical Trials
Abstract Purpose: Response Evaluation Criteria in Solid Tumors (RECIST) evaluation does not take into account the pretreatment tumor kinetics and may provide incomplete information about experimental drug activity. Tumor growth rate (TGR) allows for a dynamic and quantitative assessment of the tumor...
Na minha lista:
Principais autores: | , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2013
|
Acesso em linha: | https://doi.org/10.1158/1078-0432.ccr-13-2098 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|